方法对比
并排查看您选择的方法；存在差异的行会高亮显示。
| 群体药效学模型× | 米氏动力学× | |
|---|---|---|
| 领域 | 药理学 | 药理学 |
| 方法族 | Process / pipeline | Process / pipeline |
| 起源年份≠ | 1992 | 1913 |
| 提出者≠ | Lewis Sheiner and Stephen Roush | Leonor Michaelis and Maud Menten |
| 类型≠ | dose-response modeling | mechanistic model |
| 开创性文献≠ | Dahlström, B., & Nyberg, L. (1993). Population pharmacokinetics and pharmacodynamics. Clinical Pharmacokinetics, 24(1), 45-57. link ↗ | Michaelis, L., & Menten, M. L. (1913). Die Kinetik der Invertinwirkung. Biochemische Zeitschrift, 49, 333-369. link ↗ |
| 别名 | PopPD, population PD, hierarchical PD modeling | MM kinetics, Michaelis constant, Vmax |
| 相关≠ | 3 | 2 |
| 摘要≠ | Population pharmacodynamic (PopPD) modeling integrates pharmacokinetics with individual dose-response relationships across patient populations to characterize drug efficacy and tolerability. Pioneered by Lewis Sheiner and colleagues, PopPD accounts for inter-individual variability in drug effects and enables rational dose optimization and response prediction. | Michaelis-Menten kinetics describes the rate of enzyme-catalyzed reactions as a function of substrate concentration. Developed by Leonor Michaelis and Maud Menten in 1913, this foundational framework models enzyme catalysis through the rapid-equilibrium approximation and enables prediction of drug metabolism rates in pharmacokinetics. |
| ScholarGate数据集 ↗ |
|
|